Pfizer CEO on primary care, GLP-1 outlook and innovation timeline
Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
AI will be 'transformational' in drug development and discovery, Pfizer CEO says
Pfizer CEO Albert Bourla details $70B US investment in manufacturing and R&D, discussing oncology advancements, the GLP-1 drug race, and AI's transformative role in drug development on 'Mornings with Maria.'
The overlooked reason why new drugs take so long—and the $10 trillion fix
A new report estimates speeding up FDA drug approvals by one year could generate over $10 trillion in economic value from faster medical innovation.
Johnson & Johnson CEO credits Trump tax policy for $55B US investment push, including $1B in Florida
Johnson & Johnson says favorable tax policies, a skilled workforce and a strong investment climate helped drive its $55 billion commitment to U.S. manufacturing and research.
Philips North America CEO reveals how AI impacts healthcare efficiency
Philips North America CEO Jeff DiLullo discusses the 2026 Future Health Index explaining how AI is reshaping healthcare on 'Varney & Co.'
Wall Street makes massive bet on blood-based cancer testing
Natera co-founder Matthew Rabinowitz details the company’s pioneering work in AI-driven cancer detection on ‘Maria Bartiromo’s Wall Street.’
Trulieve CEO says medical cannabis reclassification a 'giant step forward for American healthcare'
Trulieve founder and CEO Kim Rivers discusses the impact of Trump's administration reclassifying state-licensed medical cannabis from Schedule 1 to Schedule 3 on 'Varney & Co.'
Medical device giant hit by global network disruption after cyberattack possibly linked to pro-Iranian group
Medical device giant Stryker was hit by cyberattack on Wednesday. A pro-Iranian hacktivist group allegedly claimed responsibility for the breach.
Reclassifying marijuana as a Schedule III drug opens door to medical research into its ‘positive attributes’
Green Thumb Industries founder and CEO Ben Kovler breaks down the White House’s potential move to reclassify marijuana from Schedule I to Schedule III on ‘The Claman Countdown.’
FDA commissioner unveils major reform to fast-track drug innovation
FDA Commissioner Dr. Marty Makary joins 'Varney & Co.' to discuss the FDA's plan to cut red tape, declining men's testosterone levels and his visit to Novartis' manufacturing site.
Jimmy V Week celebrates coach Valvano’s lasting legacy and fuels continued fight against cancer
Jimmy V Week honors Jim Valvano’s inspiring legacy and his foundation’s mission to fight cancer, uniting fans and athletes through hope, perseverance, and teamwork.
Pfizer wins 'fantastic deal' after $10B obesity drug fight with Novo Nordisk
Pfizer Chairman and CEO Albert Bourla joins 'Mornings with Maria' to discuss the company’s $10 billion acquisition of obesity drug startup Metsera, its competition with Novo Nordisk and his plans to expand their weight-loss drug pipeline.
Neuralink submits patient data for publishing
Fox News senior medical analyst Dr. Marc Siegel joins 'Varney & Co.' to discuss Neuralink’s newly submitted data and the connection between faith and healing in his new book 'The Miracles Among Us.'
FDA head removes emergency use authorization for COVID-19 vaccines
Fox News senior medical analyst Dr. Marc Siegel reflects on his interview with FDA Commissioner Dr. Marty Makary on ‘Varney & Co.’
Inside the male birth control study showing promising results
Fox News medical contributor Dr. Nicole Saphier joins 'Fox & Friends Weekend' to discuss a male birth control study and the side effects of women's birth control.
Nuclear waste being transformed into promising cancer treatment at former Manhattan Project site
Oak Ridge researchers are converting nuclear waste into components for targeted alpha therapy, a cancer treatment that destroys cancer cells.
China has 'weaponized students, and it's about time we recognize that': Gordon Chang
Gatestone Institute senior fellow Gordon Chang on the U.S. revoking visas for Chinese students, export controls on A.I. chips, competition for medical research and a federal court ruling against President Donald Trump's authority on tariffs.
AI bias leans left in most instances, study finds
The Hoover Institution at Stanford University conducted a study of the biases of Large Language Models of artificial intelligence and found that all models skewed left.
What else is 'unacceptable and wasteful' at the IRS?
Rep. Scott Perry, R-Pa., weighs in on Treasury Secretary Scott Bessent's vow to end the politicization of IRS audits and the NIH's 'abuse' of beagles on 'The Bottom Line.'
Dr. Oz sounds off on ‘organized effort’ to ‘defraud’ the American taxpayer
CMS administrator Dr. Mehmet Oz reveals how the Trump administration plans to revamp Medicare and Medicaid during an appearance on ‘Mornings with Maria.’